Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.01 INR | -1.35% |
|
-3.14% | -24.79% |
04-25 | Dipna Pharmachem Limited announced a financing transaction | CI |
04-02 | Dipna Pharmachem Bags INR127.5 Million Order for Melamine Powder; Shares Jump 7% | MT |
Valuation
Fiscal Period: März | 2023 |
---|---|
Capitalization 1 | 150.2 |
Enterprise Value (EV) 1 | 249.9 |
P/E ratio | 16.5 x |
Yield | - |
Capitalization / Revenue | 0.15 x |
EV / Revenue | 0.25 x |
EV / EBITDA | 10.7 x |
EV / FCF | -1,149,128 x |
FCF Yield | -0% |
Price to Book | 0.62 x |
Nbr of stocks (in thousands) | 11,970 |
Reference price 2 | 12.55 |
Announcement Date | 06/09/23 |
Income Statement Evolution (Annual data)
Fiscal Period: Maart | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 165.6 | 201.8 | 305.4 | 310 | 727.6 | 999.3 |
EBITDA 1 | 0.682 | 0.6445 | 4.296 | 3.541 | 22.47 | 23.43 |
EBIT 1 | 0.6718 | 0.5508 | 4.208 | 3.469 | 22.41 | 23.31 |
Operating Margin | 0.41% | 0.27% | 1.38% | 1.12% | 3.08% | 2.33% |
Earnings before Tax (EBT) 1 | 0.7143 | 0.5512 | 0.6001 | 0.5504 | 15.74 | 13.81 |
Net income 1 | 0.6043 | 0.3202 | 0.5902 | 0.2422 | 11.67 | 9.119 |
Net margin | 0.37% | 0.16% | 0.19% | 0.08% | 1.6% | 0.91% |
EPS 2 | 3.598 | 1.906 | 3.513 | 1.442 | 69.46 | 0.7618 |
Free Cash Flow | - | - | - | - | 20.46 | -217.5 |
FCF margin | - | - | - | - | 2.81% | -21.76% |
FCF Conversion (EBITDA) | - | - | - | - | 91.08% | - |
FCF Conversion (Net income) | - | - | - | - | 175.38% | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 03/09/19 | 03/09/19 | 02/12/20 | 29/11/21 | 15/07/22 | 06/09/23 |
Balance Sheet Analysis
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 48.1 | 58.9 | 93.8 | 122 | 99.8 | 99.7 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 70.49 x | 91.43 x | 21.83 x | 34.38 x | 4.442 x | 4.254 x |
Free Cash Flow | - | - | - | - | 20.5 | -217 |
ROE (net income / shareholders' equity) | - | 6.78% | 11.4% | 4.33% | 101% | 6.99% |
ROA (Net income/ Total Assets) | - | 0.27% | 1.62% | 1% | 4.59% | 2.56% |
Assets 1 | - | 117 | 36.47 | 24.16 | 254.2 | 356.1 |
Book Value Per Share 2 | 27.20 | 29.10 | 32.60 | 34.00 | 103.0 | 20.30 |
Cash Flow per Share 2 | 17.70 | 7.020 | 10.60 | 15.10 | 12.40 | 4.760 |
Capex | - | - | - | - | 0.07 | 0.1 |
Capex / Sales | - | - | - | - | 0.01% | 0.01% |
Announcement Date | 03/09/19 | 03/09/19 | 02/12/20 | 29/11/21 | 15/07/22 | 06/09/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-24.79% | 2.34M | |
+28.51% | 1.1B | |
+106.10% | 211M | |
+9.50% | 176M | |
+25.34% | 132M | |
-1.32% | 108M | |
+0.61% | 82.69M |
- Stock Market
- Equities
- DPL Stock
- Financials Dipna Pharmachem Limited